Enabling base editing research via automation and a cloud connected lab

Base editing — a new class of precision genetic medicines — has the potential of providing life-long cures to patients suffering from serious diseases. However, base editing research is complex and demanding, requiring the processing of large sample amounts and tracking of complex data.

In this presentation, learn how Beam Therapeutics pioneers this novel therapeutic by leveraging automation and Benchling's unified, cloud-based R&D informatics platform.

Watch now

Hosted by

Bob Gantzer
Head of Lab Automation & Robotics at BEAM Therapeutics
Lauren Shields
Head of Technical Solutions Consulting at Benchling

See Benchling in action

Helix Image